|Mr. Fredrik RÃ¥gmark||CEO & Director||N/A||N/A||1963|
|Mr. Joe Ryan||Chief Financial Officer||N/A||N/A||1965|
|Mr. Jaroslaw Urbanczyk||Chief Information Officer||N/A||N/A||1968|
|Hanna Bjellquist||Head of Investor Relations||N/A||N/A||N/A|
|Ms. Jenny Brandt||Gen. Legal Counsel||N/A||N/A||1974|
|Dr. Andrew Vallance-Owen||Chief Marketing Officer||N/A||N/A||1951|
|Ms. Liselotte Bergmark||Group Human Resource Director||N/A||N/A||1966|
|Mr. John Paul Stubbington||Chief Operating Officer of Healthcare Services||N/A||N/A||1968|
|Mr. Marcin Radziwill||Chief Exec. Officer of Medicover Foundation||N/A||N/A||N/A|
|Mr. Virgil Ivan||Managing Director of Synevo Romania - Medicover Laboratory Services||N/A||N/A||1961|
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, Sweden, India, and Hungary. The company operates in two divisions, Diagnostic Services and Healthcare Services. Its diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company offers outpatient and inpatient healthcare services, including fertility treatment, dental, elderly care, eye care, and skin and wellness services, as well as fitness and pharmacy solutions. It operates 96 clinical laboratories, 670 blood-drawing points, and 25 clinics in 10 countries; and 120 medical clinics, 21 fertility clinics, 41 dental clinics, and 20 hospitals. The company serves corporate and private customers, and patients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Medicover AB (publ)’s ISS governance QualityScore as of 2 December 2020 is 8. The pillar scores are Audit: 1; Board: 7; Shareholder rights: 10; Compensation: 1.